Venture Capital interview preparation

Questions

100

Traced to a firm

31

Firms

12

Updated

September 2026

Asked at

All firmsGeneral Atlantic9Insight Partners7Silver Lake6Vista Equity Partners4Bessemer Venture Partners3ACAccel2Advent International2Battery Ventures2Andreessen Horowitz1Coatue Management1Sequoia Capital1WPWarburg Pincus1

Topic

All topicsSourcing and deal flow5Market sizing and estimation8Founders and teams5Unit economics and cohorts11Term sheets12Cap table and dilution7Early-stage valuation7Portfolio construction6Board and governance4Down rounds and secondaries4Exits and liquidity4Fund economics5Sector theses and markets6India venture market6Fit and motivation10

Level

AnyCoreIntermediateHard

Type

AnyTechnicalFitCaseMarket viewBrainteaser

1. 049Why is it difficult to value a first-year company?Early-stage valuationIntermediatefirst roundSequoia CapitalVenture Capital · San Francisco · 2021

   Say this

   Because every valuation technique needs either cash flows or comparable multiples, and a first-year company has neither. There is no history to extrapolate, the distribution of outcomes is bimodal rather than a range, and the discount rate that would compensate for the risk is so high that a DCF produces nonsense.

   Then walk it

   1. No cash flows to discount. A DCF on a company with $200k of revenue puts 98 percent of the value in a terminal value ten years out, which means you are not valuing anything — you are writing down a guess and discounting it.
   2. No usable comparables. The company may be the first of its kind, and where comparables exist, a revenue multiple on a base of $200k gives you a number that moves by millions if the revenue moves by a rounding error.
   3. The outcome distribution is the deeper problem. A mature company's value is a range around a central case. A seed company is mostly zero with a small chance of being enormous, and an expected value calculated across a bimodal distribution does not describe any world that will actually happen.
   4. Risk is unpriceable in the normal way. The implied discount rate on seed-stage capital is somewhere between 40 and 80 percent a year. Nobody can defend a specific number in that band, and the valuation output is entirely determined by which one you pick.
   5. So what actually sets the price is not valuation at all: it is the amount the company needs for eighteen to twenty-four months, divided by the dilution the founder will accept, cross-checked against what similar rounds are clearing at this quarter. Price follows round size, not the other way round.
   6. And the investor's genuine frame is the reverse question: forget what it is worth, what does it need to become for this cheque to return the fund? At a $5m post-money for 20 percent, a $200m fund needs an exit near $1bn. Whether that is plausible is the actual decision, and it is answerable in a way that 'what is it worth' is not.

   Where candidates lose it

   Answering only 'there's no financial history'. True and shallow. The strong answer names the bimodal outcome distribution, the indefensible discount rate, and then flips to how seed prices are actually set — by round size and market convention, not by valuation technique. Then close with the fund-return test.

   Expect next

   • So how do you actually set the price?
   • What is the venture method?
   • What would you need to believe for a $5m post-money to be a good deal?

   Reported by candidates at Sequoia Capital (Venture Capital, San Francisco, 2021). Source: Wall Street Oasis.

2. 051How do you value a company on ARR multiples, and when does that break?Early-stage valuationIntermediatetechnicalGrowth equitySaaS-focused funds

   Say this

   Enterprise value divided by annual recurring revenue, benchmarked against public comparables and recent private rounds, then adjusted for growth and retention. It breaks the moment the revenue is not actually recurring, and it breaks completely as a cross-sectional comparison because the multiple is a function of growth.

   Then walk it

   1. The mechanics: take ARR, not trailing revenue — the annualised value of contracted subscriptions at a point in time. Apply a multiple from public SaaS comparables, discount it for private illiquidity and scale, then adjust up or down for growth and net retention.
   2. Growth is what the multiple is really pricing. Public software has historically traded at roughly 4 to 8 times forward revenue for 20 percent growers and 12 to 20 times for 40 percent-plus growers with good retention. Those bands have moved violently — in 2021 the top decile traded above 30 times, and the same companies traded under 10 times eighteen months later with unchanged fundamentals.
   3. That volatility is the first thing that breaks it: the multiple is a market-sentiment variable, so an ARR multiple set at the top of a cycle is not a valuation, it is a timestamp.
   4. Second break: the recurring claim. Usage-based revenue, services revenue dressed up as subscription, annual contracts with no auto-renewal, or a revenue base where the top ten customers are on pilots — none of these are ARR, and companies routinely present them as such. Ask for contracted, auto-renewing revenue only.
   5. Third break: it ignores the cost of getting the revenue. Two companies at $20m of ARR growing 50 percent are the same on this metric and completely different if one has a burn multiple of 1.2 and the other 4. That is why the multiple always has to be read against efficiency and retention.
   6. So how I would actually use it: as a sanity check and a market-clearing reference, never as the primary output. The primary work is the growth durability and retention case, and the multiple is what translates that into a price the market will accept this quarter.

   Where candidates lose it

   Quoting a multiple band without saying that it is a function of growth and retention, and without acknowledging how far those bands moved between 2021 and 2023. Also accepting the company's ARR definition — interrogating what is actually recurring is most of the real work.

   Expect next

   • What would you accept as ARR and what would you strip out?
   • Would you pay a higher multiple for 40 percent growth or 130 percent net retention?
   • How do you value a usage-based pricing model?
3. 052What discount rate would you use for a Series A company, and can you defend it?Early-stage valuationHardtechnicalEarly-stage VC

   Say this

   Practitioners use 30 to 50 percent at Series A, and honestly I cannot defend a specific number inside that band. What I can defend is the logic: the rate has to reflect the probability of total loss, and it is doing the job that a proper probability-weighted scenario model should be doing instead.

   Then walk it

   1. The conventional ladder: seed 50 to 80 percent, Series A 40 to 60, Series B 30 to 50, growth stage 20 to 35, late-stage pre-IPO 15 to 25. Those come from practitioner convention and rough realised-return data, not from CAPM.
   2. Why not CAPM: there is no observable beta for a private company with no revenue, the cash flows are not a range around a central case, and the risk is overwhelmingly idiosyncratic rather than systematic. CAPM would give you something like 12 percent, which is absurd here.
   3. What the high rate is actually doing: it is a crude substitute for the probability of zero. A 50 percent discount rate applied to a success-case forecast is another way of saying most of these companies fail.
   4. Which is why the better technique is to separate the two: forecast the success case explicitly, then probability-weight it, and discount at something closer to a normal equity rate. A 60 percent chance of failure plus a 20 percent discount rate is far more defensible and far more debatable than a single 50 percent rate with a hockey stick behind it.
   5. The practical consequence to name: at these rates, cash flows beyond year seven are worth almost nothing, so any early-stage DCF is essentially a bet on a terminal value. Discounting $100m of year-ten value at 45 percent gives you about $3m. The output is whatever you assume the terminal value is.
   6. So my honest answer is that I would not run a DCF at Series A. I would use the venture method and comparable round pricing, and I would keep the discount rate discussion for a growth-stage asset where the cash flows are real enough to discount.

   Where candidates lose it

   Producing a confident single number with a CAPM build-up behind it. An experienced interviewer will take that apart in two questions. The strong answer gives the convention, explains what the rate is standing in for, and proposes the probability-weighted alternative — then says plainly that a DCF is the wrong tool at this stage.

   Expect next

   • So would you ever run a DCF on an early-stage company?
   • How would you probability-weight the scenarios instead?
   • What rate would you use for a growth-stage company with $80m of ARR?
4. 053What is an LBO?Early-stage valuationCorephone / first roundAdvent InternationalTechnology, Media and Telecom · Palo Alto · 2020

   Say this

   Buying a company using mostly borrowed money, where the target's own cash flows service the debt. You put in a slice of equity, pay down debt over the hold with the company's cash generation, then sell — and your return comes from deleveraging, EBITDA growth and any multiple expansion.

   Then walk it

   1. Structure: a typical deal is 40 to 60 percent equity today, the rest debt, secured against the target's assets and cash flows. The debt sits on the company, not the fund.
   2. The three return drivers, and you should always name all three. Deleveraging: every rupee of debt repaid converts directly into equity value at a constant enterprise value. EBITDA growth: revenue growth plus margin improvement. Multiple expansion: exiting at a higher multiple than you paid, which is the least controllable and the one you should never underwrite.
   3. Worked version. Buy at 10x $50m of EBITDA, so $500m, with $200m equity and $300m debt. Five years later EBITDA is $75m, debt is down to $150m. Exit at 10x is $750m, less $150m of debt, so $600m of equity on $200m in. That is 3x, roughly a 25 percent IRR, with no multiple expansion assumed at all.
   4. What makes a good LBO candidate: stable, predictable cash flows, low capital intensity, a defensible market position, hard assets or contracted revenue to lend against, and an identifiable operational improvement. Cyclical, capex-heavy or pre-profit businesses are bad candidates.
   5. Why a venture investor should know this: it is increasingly the exit path. Software companies at $50m of ARR with slowing growth and positive cash flow are now bought by software-focused buyout funds rather than IPO'ing, so the LBO maths sets the floor price for a lot of venture-backed companies. Vista and Thoma Bravo have taken dozens of them private.
   6. The obvious limitation: leverage magnifies both directions. The same structure that turns a 10 percent EBITDA gain into a 30 percent equity gain turns a modest miss into a covenant breach, and it is the reason buyout funds will not touch a business whose revenue can fall 30 percent in a quarter.

   Where candidates lose it

   Describing the debt and stopping. Name the three return drivers explicitly — deleveraging, EBITDA growth, multiple expansion — because that is what the question is checking. And in a venture or growth interview, connect it to the exit path for software companies, which is why they are asking a VC candidate about LBOs at all.

   Expect next

   • What makes a good LBO candidate?
   • Which of the three return drivers matters most?
   • Why does an early-stage investor need to understand this?

   Reported by candidates at Advent International (Technology, Media and Telecom, Palo Alto, 2020). Source: Wall Street Oasis.

5. 056Explain the power law and what it actually means for how you vote in a partners' meeting.Portfolio constructionIntermediatetechnicalEarly-stage VCSeed funds

   Say this

   Venture returns are not normally distributed — a small number of investments produce most of the return, and roughly half return less than the capital invested. It means the only question that matters in a partners' meeting is whether this company could return the fund, not whether it is likely to lose money.

   Then walk it

   1. The shape: across a typical early-stage portfolio, something like 50 to 60 percent of investments return less than 1x, a middle band returns 1 to 3x, and one or two return 10x or more and produce the majority of the fund's gains.
   2. So the asymmetry is total. The downside of any single investment is capped at 1x of a small cheque; the upside is unbounded. That means the cost of a false negative — passing on the outlier — is enormously higher than the cost of a false positive.
   3. Which changes the question you ask. Not 'what is the probability this works' but 'if it works, is it big enough to return the fund?' A company with a 60 percent chance of becoming a $200m business is a worse portfolio decision than one with a 10 percent chance of becoming a $10bn business.
   4. This is why consensus voting is dangerous in venture. The companies that produce outlier returns are usually the ones that divide the partnership, because by definition consensus ideas are priced. A firm where every investment is unanimous is probably screening out its best decisions.
   5. It also dictates reserves. If one company will produce most of the return, the right behaviour is to concentrate follow-on capital into the names that are working and stop funding the middle. The hardest discipline in the job is refusing to feed a decent company that will never be an outlier.
   6. The limitation worth naming: the power law is a description of outcomes, not a licence for recklessness. It gets misused to justify paying any price for anything with a big story. The constraint is still that the portfolio has to be constructed so that one outlier is enough — which means enough shots, and enough ownership in each.

   Where candidates lose it

   Reciting 'one investment returns the fund' as a slogan. The interviewer wants the consequences: how it changes the question you ask in diligence, why it argues against consensus decisions, and what it implies for reserves. And you should name the misuse of it, because 'power law' has become the standard excuse for undisciplined pricing.

   Expect next

   • How many investments does a fund need for the power law to work?
   • So would you back a company the whole partnership disliked?
   • What does this mean for how you allocate reserves?
6. 061How do you think about signalling risk from a multi-stage fund?Portfolio constructionHardsuperdayEarly-stage VCSeed funds

   Say this

   If a fund with a large Series A vehicle writes your seed cheque and then declines to lead your A, the market reads it as inside information that the company is not working. The seed capital comes with an option the fund holds and the founder pays for.

   Then walk it

   1. The mechanism: an incoming Series A investor asks why the seed fund with $2bn under management and an obvious ability to lead is not leading. There is rarely a good answer, and the absence of one prices the round or kills it.
   2. Why it is asymmetric: the multi-stage fund gets a cheap look at fifty companies and a free option on the best few. The founder gets capital plus a hidden liability that only appears at the next raise, precisely when they have no leverage.
   3. How founders manage it: take the multi-stage seed cheque as a small, non-lead participation alongside a dedicated seed fund that has no Series A vehicle, so there is no inference to draw. Or get an explicit, written commitment about what the fund will do at the A — which is worth less than it sounds but does change the conversation.
   4. How the fund should manage it, and this is the answer they want from someone joining one: be explicit at the time of the seed investment about whether this is a scout-style option or a genuine seed position, and if you do not lead the A, say why publicly and warmly to the incoming investors. Silence is what does the damage.
   5. The counterargument is real too: multi-stage money at seed is cheaper and comes with more resource, and many founders would rather have it. Signalling risk is a cost, not a disqualifier, and founders who price it correctly still often take the money.
   6. And the honest asymmetry from the fund's side: the signal cuts the other way as well. When a top multi-stage fund does lead the A, the round prices higher and fills faster than it would otherwise. Founders are buying a positive signal along with the negative option.

   Where candidates lose it

   Describing signalling risk as a founder problem only. In an interview at a multi-stage firm, the useful answer says how the firm should behave to reduce it, because that is a live internal debate at every one of them. And do not present it as a reason multi-stage seed money is bad — it is a cost to be priced.

   Expect next

   • How would you reduce it if you ran the seed programme here?
   • Would you rather have a dedicated seed fund or a multi-stage fund lead your seed?
   • What does it mean when a seed fund does not take its pro rata?
7. 062What does a venture investor actually do on a board?Board and governanceCoretechnicalGrowth equityIndian venture capital

   Say this

   Three real jobs: hire and if necessary replace the CEO, approve the things that cannot be undone, and make sure the company does not run out of money by accident. Everything else — advice, introductions, recruiting help — is valuable but is not a board function, and confusing the two is how directors overstep.

   Then walk it

   1. The fiduciary duty runs to the company and all shareholders, not to the fund that appointed you. That distinction matters in practice, because the moment a sale price is being negotiated your fund's preference and the common's interests diverge, and a director who behaves as the fund's agent creates real legal exposure.
   2. The formal work: approve the budget, approve financings and option grants, approve a sale, and set CEO compensation. Roughly six meetings a year, plus a lot of between-meeting contact that is where the actual influence sits.
   3. The single most important decision a venture board makes is whether the CEO is the right CEO for the next stage. It is rare, it is painful, and boards are systematically too slow at it — the modal error is eighteen months of hoping.
   4. The cash-watch job: knowing the runway to the month, forcing the conversation about the next raise nine months before the cash runs out rather than three, and being honest about whether the fund will support a bridge. A board that lets a company drift into a two-month cash position has failed.
   5. Then the non-board value-add, which is most of what a founder actually wants: candidate introductions, customer introductions, pricing and go-to-market pattern recognition, and being the person the CEO can say 'I am out of my depth' to. That last one requires you to have never punished honesty in a board meeting.
   6. The discipline to state: the board does not run the company. A director who starts directing functional decisions destroys the CEO's authority with their own team, and the good ones ask questions in the meeting and give opinions outside it.

   Where candidates lose it

   Answering with the value-add list — introductions, advice, coaching — and never naming the fiduciary role or the CEO decision. Those are the board's actual powers. And missing that your duty is to all shareholders rather than to your fund, which is the question behind most board-conflict scenarios.

   Expect next

   • What happens when your fund's interests and the common shareholders' diverge?
   • How would you handle a CEO who needs replacing?
   • What is the difference between a board seat and an observer seat?
8. 064What should the board look like at Series A, and what changes by Series C?Board and governanceIntermediatetechnicalGrowth equity

   Say this

   At Series A, five seats: two founders, the Series A lead, the seed investor or a second common seat, and one genuinely independent director. By Series C it grows to seven with more investor and independent seats, and the founders no longer control it — which is the real change.

   Then walk it

   1. The standard Series A structure is two common, one preferred, and two independents agreed by both sides, or the simpler three-two split with founders holding the majority. Either way the founders still effectively control the board at the A, and that is normal and healthy.
   2. The independent seat is the one most people undervalue. It is the tie-breaker, and if you pick someone with genuine operating experience at the next stage of scale, they contribute more than any investor director does. The mistake is leaving it empty for two years, which happens constantly.
   3. By Series B and C, each new lead wants a seat and the board drifts to seven or nine. At some point the investor plus independent seats outnumber the founders, and control has shifted. Founders often do not register the moment it happens because it arrives one seat at a time.
   4. So the counter-discipline: cap the board at seven, move later investors to observer status rather than full seats, and add independents rather than investors as the company scales. A nine-person venture board does not make better decisions, it makes slower ones and pushes the real conversations into side calls.
   5. What also changes by Series C is the work. An A board is about product-market fit, hiring and the next raise. A C board is about operating discipline, the finance function, audit and compensation committees, and starting to think about what a public company or an acquisition needs.
   6. And a governance detail worth knowing: founders preserve control through mechanisms other than board seats — super-voting shares, or a voting agreement that ties specific seats to whoever holds the founder shares. Board composition and voting control are separate levers and sophisticated founders manage both.

   Where candidates lose it

   Describing a board as just a headcount. The substance is who controls it, when control shifts, and that independents are more valuable than extra investor seats. Also failing to distinguish board control from voting control — they are separate and founders often keep one while losing the other.

   Expect next

   • At what point do the founders lose board control, and does it matter?
   • How would you choose an independent director?
   • Would you take an observer seat instead of a board seat?
9. 068Why is a structured round often worse for a company than a clean down round?Down rounds and secondariesHardsuperdayLate-stage VCGrowth equity

   Say this

   Because it preserves the headline valuation by burying the real price in terms nobody outside the deal can see. The company looks like it raised flat, but a 2x senior participating preference with a full ratchet means the common is worth far less than in an honest down round at a lower price.

   Then walk it

   1. What structure means in practice: multiple liquidation preference, participation, senior rather than pari passu ranking, full ratchet anti-dilution, guaranteed IPO returns or ratchets on the IPO price. Each one transfers value from common to the new preferred without touching the headline number.
   2. Run it. A flat $500m round with $150m of new money at 2x senior participating means the first $300m of any exit goes to the new investor before anyone else sees a rupee. At a $400m exit, the common gets almost nothing — worse than if the round had simply priced at $200m with clean terms.
   3. The second cost is compounding: structure is senior and it stacks. The next investor demands terms at least as good, so you get a tower of preferences, and by the third round the common is a call option struck impossibly high. Employees work out that their options are worthless well before the board admits it.
   4. The third cost is optionality on exit. A heavy preference stack means a $300m sale pays management nothing, so the team will not sell, so the company keeps raising. Structure removes the reasonable exits and forces an all-or-nothing outcome.
   5. The clean alternative: reset the price, take the dilution, refresh the option pool, and keep the stack at 1x non-participating. Everyone knows where they stand, the recruiting story is honest, and a mid-sized exit still pays the team.
   6. This was the defining mistake of the 2021 to 2022 period. A lot of companies protected a unicorn headline with structure and discovered two years later that the structure, not the valuation, was what made them unfinanceable and unsellable. Being able to say that with a specific example is what makes this answer land.

   Where candidates lose it

   Treating a flat round as good news. Any time a valuation holds in a bad market, the first question is what the terms were. A candidate who does not ask for the preference stack before commenting on a valuation has not understood how late-stage rounds are actually priced.

   Expect next

   • What is an IPO ratchet and who does it hurt?
   • How would you find out whether a reported valuation was structured?
   • As the founder, which would you choose and why?
10. 069Would you sell a position in the secondary market, and how is secondary priced?Down rounds and secondariesIntermediatetechnicalSecondariesGrowth equity

    Say this

    Yes, in three situations: the position has grown so large it dominates the fund, the fund is at the end of its life and needs to return capital, or my view has changed but the company is still marked up. Pricing is typically a discount to the last round, with the discount reflecting information asymmetry and the buyer's lack of rights.

    Then walk it

    1. Pricing mechanics: secondary trades reference the last primary round price, then discount it. Direct secondaries in strong companies can trade near or above the last round; ordinary positions in reasonable companies trade at 20 to 40 percent discounts; and in a weak market or a company that has not raised for two years, discounts of 50 to 70 percent are normal.
    2. What drives the discount: how stale the last round is, whether the buyer gets information rights or is buying blind, whether the shares are common or preferred, and transfer restrictions — most private companies have rights of first refusal and board consent on transfers, which alone knocks off value.
    3. Why a fund sells. First, concentration: a position at 40 percent of fund NAV is a risk-management problem regardless of conviction. Second, fund life — a ten-year fund in year eleven has LPs who want cash, and DPI is the number they judge you on. Third, a changed view while the mark is still good.
    4. The other side of it, which is the more interesting answer in an interview: buying secondary. Late-stage secondary is where a lot of the best risk-adjusted venture returns have sat since 2022, because you can buy a company with real revenue at a large discount to a price that was set in a completely different market. The diligence problem is that you may get no access to the company.
    5. Then the structures: direct secondary from an early investor or employee, an LP-interest sale of a whole fund stake, a continuation vehicle where the GP moves assets into a new fund with new capital, or a strip sale of several positions. Each has different pricing and different conflicts.
    6. And the conflict I would name: a GP selling to a continuation fund they also manage is on both sides of the trade. That requires an independent valuation and an LP advisory committee sign-off, and it is the governance issue LPs currently care most about.

    Where candidates lose it

    Treating secondary as a distressed-only market. Since 2022 it has been a core part of how venture liquidity works, and employee tender offers and continuation vehicles are routine. Also quoting a discount without naming what drives it — staleness, rights, and transfer restrictions are the three levers.

    Expect next

    • How would you diligence a secondary position with no access to the company?
    • What is a continuation vehicle and what is the conflict?
    • Would you buy or sell in today's market?

Firm tags come from public, anonymous candidate reports on Wall Street Oasis: strong signal, not sworn testimony. Firms are named as the places a question was reported, not as partners of Fin Maverick. Answers are written for this page to show how to think out loud; they are not scripts to recite.